<DOC>
	<DOCNO>NCT02131233</DOCNO>
	<brief_summary>To evaluate safety efficacy reformulate raltegravir ( MK-0518 ) 1200 mg daily combination TRUVADA™ versus raltegravir 400 mg twice daily combination TRUVADA™ HIV-1 infect , treatment-naive participant . The primary hypothesis test reformulate raltegravir 1200 mg once-daily non-inferior raltegravir 400 mg twice-daily , combination therapy TRUVADA™ , assess proportion participant achieve HIV-1 ribonucleic acid ( RNA ) &lt; 40 copies/mL Week 48 .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Reformulated Raltegravir ( MK-0518 ) 1200 mg Once Daily Combination With TRUVADA™ Human Immunodeficiency Virus ( HIV ) -1 Infected , Treatment-Naive Participants ( MK-0518-292 )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>HIV1 positive Naïve antiretroviral therapy include investigational antiretroviral agent Not reproductive potential , reproductive potential agree 1 ) true abstinence , 2 ) use acceptable method birth control study Use recreational illicit drug recent history drug alcohol abuse dependence Has treat viral infection HIV1 ( hepatitis B ) agent active HIV1 include limited adefovir , tenofovir , entecavir , emtricitabine , lamivudine Has document know resistance raltegravir , emtricitabine , and/or tenofovir first dose study drug Has participate study investigational compound device within 30 day anticipate participate study study Has use systemic immunosuppressive therapy immune modulators within 30 day anticipate need study ( short course corticosteroid allow ) Requires anticipate require follow prohibited medication study : phenobarbital , phenytoin , rifampin , rifabutin , calcium , magnesium aluminum contain antacid , TUMS™ , Maalox™ Milk Magnesia™ Has significant hypersensitivity contraindication component study drug Has current , active diagnosis acute hepatitis due cause Is pregnant , breastfeeding , expect conceive study Female participant expect donate egg male participant expect donate sperm study Is family member ( spouse child ) investigational staff sponsor staff directly involve trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>